Search clinical trials for: Ursodeoxycholic acid (UDCA) 500 mg

Total 4177 results

Fundacion para la Formacion e Investigacion Sanitarias...

Completed

Gestational Treatment With Ursodeoxycholic Acid Compared to Placebo to Reduce Severity of Gestational Diabetes Mellitus Diagnosed at 24-28 Weeks' Gestation (GUARDS)

Gestational Diabetes

Spain
Tanta University

Recruiting

Evaluating the Effect of Ursodeoxycholic Acid in Patients With Rheumatoid Arthritis

Rheumatoid Arthritis

Egypt
Beijing Trendful Kangjian Medical Information Consulting...

Completed

Efficacy and Safety Study of TUDCA Compare UDCA to Treatment Chronic Cholestatic Liver Disease-PBC

Cholestatic Liver Disease

China
University of Tennessee
University of Colorado, Denver; Baylor College of Medicine; Children's Hospital... and other collaborators

Completed

Safety and Efficacy Study of Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis

Primary Sclerosing Cholangitis

United States
Stanford University

Recruiting

The Role of Secondary Bile Acids in Intestinal Inflammation

Ulcerative Colitis | Pouchitis

United States
Daewoong Pharmaceutical Co. LTD.

Completed

A Multiple Dose Study of DWP10292 and UDCA in Healthy Male Subjects

Healthy
Peking Union Medical College Hospital

Recruiting

Clinical Research of UCDA Reducing Medication Regimen in Stable PBC (UCDA PBC)

Primary Biliary Cholangitis

China
Sahlgrenska University Hospital, Sweden

Completed

Ursodeoxycholic Acid in Bariatric Surgery

Non-alcoholic Fatty Liver Disease | Morbid Obesity
First Affiliated Hospital Xi'an Jiaotong University

Recruiting

Effect of UDCA on the New Onset Diabetes and Glucose Intolerance Induced by Statin

Diabetes Mellitus

China
Tanta University

Completed

Evaluating the Effect of Digoxin and Ursodeoxycholic Acid in Patients With Rheumatoid Arthritis

Rheumatoid Arthritis

Egypt
Beijing Ditan Hospital

Recruiting

UDCA in the Treatment of COVID-19 Infection and Its Clinical Prognosis in Patients With Autoimmune Liver Disease

COVID-19 Infection

China
Dr. Falk Pharma GmbH

Completed

Ursofalk Tablets (500 mg) Versus Ursofalk Capsules (250 mg) in the Treatment of Primary Biliary Cirrhosis

Primary Biliary Cirrhosis

Germany
Daewoong Pharmaceutical Co. LTD.

Completed

An Exploratory Clinical Trial to Evaluate and Compare Safety and Pharmacokinetic Characteristics After Administration of the DWJ1439, DWJ1464, DWC202108 or DWC202109 in Healthy Adult Volunteers

Healthy Subject

Korea, Democratic People's Republic of
Robert Chunhua Zhao, MD, PhD
Peking Union Medical College Hospital

Unknown

Efficacy and Safety Study of Allogenic Mesenchymal Stem Cells for Patients With Refractory Primary Biliary Cirrhosis (MSCsTreatPBC)

Primary Biliary Cirrhosis

China
University of Leipzig
Hannover Medical School; RWTH Aachen University; Academisch Medisch Centrum -... and other collaborators

Recruiting

Prospective, Multicenter Cohort Study on Primary Biliary Cholangitis (PBC-Cohort)

Primary Biliary Cholangitis | PBC

Germany
Yungjin Pharm. Co., Ltd.

Completed

Safety, Tolerability and Pharmacokinetic Study of KL1333 in Healthy Male Volunteers

MELAS Syndrome | Mitochondrial Respiratory Chain Deficiencies

Korea, Republic of
Oregon Health and Science University
Huntington Study Group; Huntington Society of Canada

Unknown

Ursodiol in Huntington's Disease (UDCA-HD)

Huntington Disease

United States
Ethan Weinberg
American Association for the Study of Liver Diseases; Meridian Bioscience,...

Terminated

Ursodeoxycholic Acid (UDCA) for Hepatic Sarcoidosis

Hepatic Sarcoidosis, Elevated Alkaline Phosphatase

United States
Vanderbilt University Medical Center

Terminated

Examination of the Metabolic Effects of Direct Bile Salt Delivery to the Ileum in Humans

Glucose Intolerance | Gastric Bypass Surgery

United States
Gannex Pharma Co., Ltd.
Ascletis Pharmaceuticals Co., Ltd.

Recruiting

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASC61in Subjects With Advanced Solid Tumors

Advanced Solid Tumors

United States
University Clinical Centre of Kosova
University of Zagreb

Unknown

The Effect of Ursodeoxycholic Acid in Liver Functional Restoration of Patients With Obstructive Jaundice

Obstructive Jaundice

Serbia
US Department of Veterans Affairs

Completed

Clinical Studies on Bile Acids in Barrett's Esophagus

Gastroesophageal Reflux Disease

United States
National Institute of Diabetes and Digestive and...

Terminated

Trial of High-dose Urso in Primary Sclerosing Cholangitis

Primary Sclerosing Cholangitis

United States
Mirum Pharmaceuticals, Inc.

Completed

Phase 2 Study to Evaluate LUM001 in Combination With Ursodeoxycholic Acid in Patients With Primary Biliary Cirrhosis (CLARITY)

Primary Biliary Cirrhosis | PBC

United States, United Kingdom, Canada
Wenzhou Medical University

Unknown

Autologous Bone Marrow Stem Cells Infusion for the Treatment of Liver Diseases. (ABMSCIFTLD)

Liver Diseases

China
Intercept Pharmaceuticals

Terminated

Study of INT 747 in Combination With URSO in Patients With Primay Biliary Cirrhosis (PBC)

Liver Cirrhosis, Biliary

United States, Spain, Canada, United Kingdom, France, Germany, Austria, Netherlands
University of Banja Luka

Enrolling by invitation

Efficacy of Ursodeoxycholic Acid (UDCA) in Patients With Type 2 Diabetes

Diabetes Mellitus, Type 2

Bosnia and Herzegovina
Taipei Veterans General Hospital, Taiwan

Unknown

Cholestatic Drug-induced Liver Injury (DILI)

Hepatitis, Toxic

Taiwan
Daewoong Pharmaceutical Co. LTD.

Recruiting

To Evaluate Efficacy of Ursodeoxycholic Acid (UDCA) for the Prevention of Gallstone Formation After Gasterectomy

Gastric Cancer

Korea, Republic of
Xijing Hospital of Digestive Diseases

Recruiting

Fenofibrate Combined With Ursodeoxycholic Acid in Subjects With Primary Biliary Cholangitis

Primary Biliary Cholangitis

China
CVI Pharmaceuticals

Unknown

Safety and Efficacy of CVI-LM001 in Patients With Hypercholesterolemia

Hyperlipidemia

China
Lexicon Pharmaceuticals

Completed

A Study to Determine the Safety and Efficacy of LX3305 in Subjects With Active Rheumatoid Arthritis

Rheumatoid Arthritis

United States
Guangdong Zhongsheng Pharmaceutical Co., Ltd.

Completed

The Safety, Tolerability and Pharmacokinetic Study of ZSP1273 in Healthy Volunteers.

Influenza

China
Daewoong Pharmaceutical Co. LTD.

Completed

A Single-dose, Comparative Bioavailability Study of Two Formulations of Ursodiol 500mg Tablets Under Fasting Conditions

Healthy

Canada
Daewoong Pharmaceutical Co. LTD.

Completed

A Single-dose, Comparative Bioavailability Study of Two Formulations of Ursodiol 500mg Tablets Under Fed Conditions

Healthy

Canada
National Cancer Institute (NCI)

Completed

Ursodiol in Treating Patients With Barrett Esophagus and Low-Grade Dysplasia

Barrett Esophagus | Esophageal Carcinoma

United States
Aevi Genomic Medicine, LLC, a Cerecor company

Completed

Pharmacokinetic and Tolerability Study of NFC-1 in Subjects Aged 6-17 Years With ADHD

Attention Deficit Disorder With Hyperactivity

United States
Wei Liu

Recruiting

Ursodeoxycholic Acid Prevents Total Parenteral Nutrition Cholestasis (UDACPPNAC)

Cholestasis of Parenteral Nutrition

China
Pfizer

Withdrawn

A Study To Evaluate The Safety And Efficacy Of PF-06826647 In Participants With Moderate To Severe Ulcerative Colitis

Ulcerative Colitis

United States
CymaBay Therapeutics, Inc.

Completed

Study Investigating the Safety, Tolerability, and PK, PD, of CB-0406

Healthy Volunteers

Australia
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Completed

Tolerability and Pharmacokinetics of CSPCHA115 Capsules in Chinese Healthy Volunteers

Asthma; Allergic Rhinitis

China
Guangdong Raynovent Biotech Co., Ltd

Completed

Study of ZSP1273 in Patients With Acute Uncomplicated Influenza A

Influenza A

China
GlaxoSmithKline

Completed

A Dose Ranging Study to Evaluate the Safety and Efficacy of GSK2586184 in Patients With Chronic Plaque Psoriasis

Psoriasis

Germany, United Kingdom
Zhejiang Hisun Pharmaceutical Co. Ltd.

Unknown

Trial of Ginsenoside Compound K (GCK) Tablet in Patients With Rheumatoid Arthritis

Early Rheumatoid Arthritis

China
Ridgeback Biotherapeutics, LP
Merck Sharp & Dohme LLC

Completed

Safety, Tolerability and Efficacy of Molnupiravir (EIDD-2801) to Eliminate Infectious Virus Detection in Persons With COVID-19

SARS-CoV-2 Infection, COVID-19

United States
Innovation Pharmaceuticals, Inc.

Completed

Efficacy and Safety of Prurisol Administered Orally for Active Moderate to Severe Chronic Plaque Psoriasis

Chronic Stable Plaque Psoriasis

United States
Galapagos NV

Completed

A Study to Evaluate Multiple Doses of GLPG2222 in Adult Subjects With Cystic Fibrosis

Cystic Fibrosis

Spain, United Kingdom, United States, Netherlands, Belgium, Serbia
GlaxoSmithKline

Terminated

An Adaptive Phase II Study to Evaluate the Efficacy, Pharmacodynamics, Safety and Tolerability of GSK2586184

Systemic Lupus Erythematosus

Estonia, Germany, South Africa, Peru, Sweden, France, Korea, Republic of, Hong Kong, Spain, Romania, Czechia, Argentina, Chile, Hungary, Greece, Poland
Tibotec Pharmaceuticals, Ireland

Withdrawn

PEPI-TiDP23-C104 is a First in Human Study With a Single Dose Escalation Part and a Multiple Dosing Part for Compounds TMC589337 and TMC589354.

HIV Infections

Netherlands
Janssen Research & Development, LLC

Completed

A Safety and Pharmacokinetics Study of CNTO 3157 in Healthy Japanese and Caucasian Participants

Healthy

United States

Search clinical trials for: Ursodeoxycholic acid (UDCA) 500 mg

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Tanzania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations